Enzolytics Inc
Change company Symbol lookup
Select an option...
ENZC Enzolytics Inc
GREE Greenidge Generation Holdings Inc
MLM Martin Marietta Materials Inc
ERESW East Resources Acquisition Equity Warrant Exp 1st July 2027 *W EXP 07/01/2027
NRAC Noble Rock Acquisition Corp
DCGO DocGo Inc
VELOW Velocity Acquisition Equity Warrant Exp 24 Feb 2028 *W EXP 02/24/2028
MRC MRC Global Inc
BAC Bank of America Corp
BKR Baker Hughes Co
Go

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Closing Price
$0.0737
Day's Change
0.0027 (3.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0821
Day's Low
0.0701
Volume
(Light)
Volume:
5,325,554

10-day average volume:
9,319,420
5,325,554

Netflix raising U.S. prices, standard plan to top $15 a month

4:17 pm ET January 14, 2022 (MarketWatch)
Print

By Jeremy C. Owens and Jon Swartz

First price increase for North America since October of 2020 arrives as Netflix is expected to disappoint on subscriber growth in coming earnings report, stock jumped Friday after news hits

Netflix Inc. plans to raise its rates for streaming subscriptions in the U.S. and Canada for the second time during the COVID-19 pandemic, which led to huge early subscriber growth for the company that slowed down in 2021.

Netflix's (NFLX)website was updated with new price listings Friday. The standard plan in the U.S., which allows two streams at high-definition quality, will now cost $15.49 a month, up from $13.99 a month. The two other main U.S. subscription plans increased as well, with the basic plan moving to $9.99 from $8.99 and the Premium plan increasing to $19.99 from $17.99. In Canada, the standard plan will reportedly increase to C$16.49 from C$14.99.

"We understand people have more entertainment choices than ever and we're committed to delivering an even better experience for our members," a Netflix spokesperson told Reuters, which first published the news. "We're updating our prices so that we can continue to offer a wide variety of quality entertainment options. As always we offer a range of plans so members can pick a price that works for their budget."

The company, which spent $17 billion on programming in 2021, has not disclosed how much it intends to spend this year.

Netflix previously raised prices in October 2020, pushing the standard plan from $12.99 to $13.99 and the premium plan, which allows for up to four concurrent streams, to $17.99 from $15.99. That increase happened just as subscriber growth began to slow down for Netflix, after the company added more than 25.8 million net new subscribers in the first half of 2020, when the pandemic first struck and led to a wave of shelter-in-place orders.

For more: Your streaming subscriptions reshaped Disney and turbocharged Netflix -- now comes making more money off you

In the full year after that explosion, from mid-2020 to mid-2021, Netflix attracted fewer than 17 million net new subscribers and fewer than 1 million on a net basis in North America. The company has been leaning on international markets for growth, even slashing prices in India, where competition with Amazon.com Inc. (AMZN) and Walt Disney Co. (DIS) is fierce.

Netflix executives' forecast for the holiday quarter called for 8.5 million net new subscribers, but some analysts believe that projection was too optimistic. The streaming service is scheduled to report fourth-quarter earnings on Thursday, Jan. 27.

Netflix shares received a warm response to news of the higher consumer prices, jumping from around $515 a share to more than $530 at noon Pacific time, when Reuters published the news. The stock has struggled under the weight of declining subscriber growth, gaining 6.1% in the past year as the S&P 500 index has increased 22.8%.

-Jeremy C. Owens

	

(END) Dow Jones Newswires

January 14, 2022 16:17 ET (21:17 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.